Eric Lefkofsky Leading the Way for Data-Enabled Medicine

Eric Lefkofsky is changing the way cancer treatment is viewed.

Lefkofsky is the co-founder and chairman of Groupon, but he’s also made a significant impact on the healthcare industry. He is the co-founder and CEO of Tempus. Tempus has been striving for data-driven cancer treatment. This is the result of Lefkofsky’s donations to cancer research.

As the number of adults facing a cancer diagnosis in the United States draws near 40 percent, new ways to battle the disease are constantly being sought after. The search is now more crucial than ever, as 19 million U.S. citizens are expected to live with cancer by the year 2024. To maximize precision, Lefkofsky has focused on data-based medicine.

Tempus has created an operating system to fight cancer. The idea is a patient’s clinical and molecular data can be analyzed to great effect to maximize the chance of recovery. It wasn’t easy for Tempus to reach this point, as the cost of the data as well as accessibility caused some issues and learn more about Eric.

Advancements in science and technology have helped alleviate this problem. The cost of obtaining genomic information through human genome sequencing was cut down from $100 million in 2003 to just $5,000. Thanks to companies such as Tempus, that cost is expected to be reduced and more information click here.

When Lefkofsky left his position as the CEO of Groupon, he put his focus on Tempus. At the time, not much was known about the company other than it was a health-tech startup with the goal of modernizing cancer treatment. Over one year later, Tempus has made their mission clear.

While Lefkofsky was born in Michigan, he now resides in Chicago. There, he performs his duties at Tempus and is on the board of directors of Lurie’s Children’s Memorial Hospital in Chicago. His efforts for a cancer-free country have not gone unnoticed and Eric’s lacrosse camp.